Skip to Main Content

Advertisement

Skip Nav Destination

In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS).

J Exp Med (1994) 180 (6): 2199–2208.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal